Your browser doesn't support javascript.
loading
Population-based incidence of lymphomas in the French Nord-Pas-de-Calais region between 2001 and 2005: Annual estimations and spatial analysis.
Detourmignies, L; Leroyer, A; Ligier, K; Plouvier, S; Genin, M.
Afiliación
  • Detourmignies L; Service d'hématologie clinique, Hôpital de Roubaix, 11-17, boulevard Lacordaire, 59056 Roubaix, France. Electronic address: laurence.detourmignies@ch-roubaix.fr.
  • Leroyer A; Université de Lille, CHU de Lille, Institut Pasteur de Lille, EA 4483, IMPECS, IMPact of Environmental Chemicals on human health, 59000 Lille, France; CHU de Lille, Pôle de Santé Publique, 59000 Lille, France; Institut Pasteur de Lille, 59000 Lille, France.
  • Ligier K; Registre général des cancers de Lille et de sa région, C2RC, 59037 Lille, France; Conseil Départemental du Pas-de-Calais, 62018 Arras, France.
  • Plouvier S; Registre général des cancers de Lille et de sa région, C2RC, 59037 Lille, France.
  • Genin M; Université de Lille, EA 2694 - Santé Publique : épidémiologie et qualité des soins, 59000 Lille, France.
Rev Epidemiol Sante Publique ; 67(5): 319-327, 2019 Sep.
Article en En | MEDLINE | ID: mdl-31327522
ABSTRACT

BACKGROUND:

Non-Hodgkin's lymphomas (NHL) are the seventh most commonly diagnosed cancer in France. Nord-Pas-de-Calais is ranked as the region with the highest incidence of cancers and deaths by cancer in France. With its rich industrial past and its contrasted population densities between urban and rural territories, Nord-Pas-de-Calais represents a geographic area of interest to study the overall incidence of NHL and examine spatial variation of NHL incidence between the 170 cantons of the region.

METHODS:

LYMPHONOR was a population-based multicentre retrospective study of patients residing in the Nord-Pas-de-Calais region and diagnosed with NHL between January 2001 and December 2005. Spatial distribution of NHL incidence in Nord-Pas-de-Calais was explored using two complementary approaches adjusted smoothed standardised incidence ratio (SIR) and spatial scan statistics (detection of atypical clusters).

RESULTS:

Between 2001 and 2005, 2132 new cases of NHL were diagnosed in the Nord-Pas-de-Calais region. In 2005, age-standardised NHL incidence rates were 10.2 and 7.0 cases per 100,000 person-years in male and female residents, respectively. No significant spatial disparities in NHL incidence were found within the Nord-Pas-de-Calais region. The age-adjusted smoothed SIR varied from 0.82 to 1.25 between cantons. Consistently, spatial scan statistics did not detect any significant atypical cluster of high NHL incidence.

CONCLUSION:

Comparison with national data collected during the same period does not show an overincidence of NHL in the Nord-Pas-de-Calais region. In addition, no evidence for spatial heterogeneity and clustering of NHL incidence was found within this region. Future epidemiological research using large-scale registries is needed to better appraise spatial variation of NHL incidence in France and to investigate possible reasons for significant clusters.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfoma Tipo de estudio: Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Infant / Male País/Región como asunto: Europa Idioma: En Revista: Rev Epidemiol Sante Publique Año: 2019 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfoma Tipo de estudio: Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Infant / Male País/Región como asunto: Europa Idioma: En Revista: Rev Epidemiol Sante Publique Año: 2019 Tipo del documento: Article